Keng Shen

880 total citations
40 papers, 602 citations indexed

About

Keng Shen is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Keng Shen has authored 40 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in Keng Shen's work include Cancer-related molecular mechanisms research (10 papers), Extracellular vesicles in disease (5 papers) and Cancer Research and Treatments (5 papers). Keng Shen is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Extracellular vesicles in disease (5 papers) and Cancer Research and Treatments (5 papers). Keng Shen collaborates with scholars based in China, United Kingdom and United States. Keng Shen's co-authors include Jianfang Zeng, Haixia Li, Dongyan Cao, Shiping Liu, Jiaxin Yang, Ting Gui, Ding Ma, Qifeng Yang, Guohong Hu and Xing Xie and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Keng Shen

38 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keng Shen China 13 455 309 105 92 52 40 602
Chieh-Yang Cheng Taiwan 8 385 0.8× 133 0.4× 115 1.1× 185 2.0× 54 1.0× 12 611
Yu‐Chun Weng Taiwan 10 261 0.6× 126 0.4× 65 0.6× 59 0.6× 53 1.0× 22 418
Han‐Hsuan Fu United States 9 406 0.9× 237 0.8× 122 1.2× 413 4.5× 148 2.8× 10 758
Michael Conner United States 4 338 0.7× 103 0.3× 106 1.0× 213 2.3× 38 0.7× 6 554
Yung-Chieh Chang Taiwan 10 343 0.8× 76 0.2× 53 0.5× 137 1.5× 55 1.1× 15 520
Xupeng Yue China 13 333 0.7× 214 0.7× 24 0.2× 96 1.0× 78 1.5× 16 532
Ruixiu Zhang China 10 272 0.6× 138 0.4× 38 0.4× 202 2.2× 63 1.2× 18 492
Lucas Fass United States 3 208 0.5× 95 0.3× 85 0.8× 126 1.4× 100 1.9× 9 446
Bala Gür Dedeoğlu Türkiye 15 347 0.8× 195 0.6× 32 0.3× 122 1.3× 32 0.6× 33 494
Yingxia Ning China 10 212 0.5× 147 0.5× 24 0.2× 109 1.2× 49 0.9× 20 354

Countries citing papers authored by Keng Shen

Since Specialization
Citations

This map shows the geographic impact of Keng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keng Shen more than expected).

Fields of papers citing papers by Keng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keng Shen. The network helps show where Keng Shen may publish in the future.

Co-authorship network of co-authors of Keng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Keng Shen. A scholar is included among the top collaborators of Keng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keng Shen. Keng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gui, Ting, et al.. (2021). Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods. PLoS ONE. 16(6). e0253136–e0253136. 13 indexed citations
3.
Li, Lei, Jinguang Wu, Shifu Weng, et al.. (2020). <p>Fourier Transform Infrared Spectroscopy Monitoring of Dihydroartemisinin-Induced Growth Inhibition in Ovarian Cancer Cells and Normal Ovarian Surface Epithelial Cells</p>. Cancer Management and Research. Volume 12. 653–661. 11 indexed citations
4.
Peng, Peng, Wei Zhang, Dongyan Cao, Jiaxin Yang, & Keng Shen. (2019). The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects. Translational Cancer Research. 8(2). 452–465. 3 indexed citations
5.
Zhang, Wei, Jiaxin Yang, Dongyan Cao, et al.. (2016). Regulation of exosomes released from normal ovarian epithelial cells and ovarian cancer cells. Tumor Biology. 37(12). 15763–15771. 19 indexed citations
6.
Liu, Shiping, Xuan Jiang, Weihua Li, et al.. (2016). Inhibition of the long non-coding RNA MALAT1 suppresses tumorigenicity and induces apoptosis in the human ovarian cancer SKOV3 cell line. Oncology Letters. 11(6). 3686–3692. 27 indexed citations
7.
8.
Fu, Yibing, Jing Chen, Bo Pang, et al.. (2014). EZH2-Induced H3K27me3 is Associated with Epigenetic Repression of the ARHI Tumor-Suppressor Gene in Ovarian Cancer. Cell Biochemistry and Biophysics. 71(1). 105–112. 32 indexed citations
9.
Li, Haixia, Jianfang Zeng, & Keng Shen. (2014). PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer. Archives of Gynecology and Obstetrics. 290(6). 1067–1078. 170 indexed citations
10.
Shen, Keng, Ting Gui, Huimin Bai, et al.. (2014). Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins. OncoTargets and Therapy. 7. 1705–1705. 17 indexed citations
11.
Song, Yue, et al.. (2014). Sequential combination of flavopiridol with Taxol synergistically suppresses human ovarian carcinoma growth. Archives of Gynecology and Obstetrics. 291(1). 143–150. 9 indexed citations
12.
Song, Yue, et al.. (2013). Autocatalytic Caspase-3 Driven by Human Telomerase Reverse Transcriptase Promoter Suppresses Human Ovarian Carcinoma Growth In Vitro and in Mice. International Journal of Gynecological Cancer. 23(4). 642–649. 3 indexed citations
13.
Kong, Beihua, Qing Zhang, Guohong Hu, et al.. (2013). A multiplex methylation-specific PCR assay for detection of early-stage ovarian cancer using cell-free serum DNA.. Journal of Clinical Oncology. 31(15_suppl). 5535–5535. 1 indexed citations
14.
Gui, Ting & Keng Shen. (2012). miRNA-101: A potential target for tumor therapy. Cancer Epidemiology. 36(6). 537–540. 25 indexed citations
15.
Wang, Wei, Xi Xia, Shusen Wang, et al.. (2011). Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy. Cancer Gene Therapy. 18(11). 825–836. 9 indexed citations
16.
Sun, Lulu, Dongyan Cao, Jiaxin Yang, et al.. (2011). Population-based case–control study on DAPK1, RAR-β2 and MGMT methylation in liquid-based cytology. Archives of Gynecology and Obstetrics. 285(5). 1433–1439. 13 indexed citations
17.
18.
Tan, Xianjie, et al.. (2008). [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].. PubMed. 30(4). 274–8. 2 indexed citations
19.
Shen, Keng, et al.. (2007). [The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis].. PubMed. 87(25). 1738–41. 4 indexed citations
20.
Song, Yue, et al.. (2007). [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].. PubMed. 42(11). 761–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chieh-Yang Cheng Breakdown of academic impact, for papers by Yu‐Chun Weng Breakdown of academic impact, for papers by Han‐Hsuan Fu Breakdown of academic impact, for papers by Michael Conner Breakdown of academic impact, for papers by Yung-Chieh Chang Breakdown of academic impact, for papers by Xupeng Yue Breakdown of academic impact, for papers by Ruixiu Zhang Breakdown of academic impact, for papers by Lucas Fass Breakdown of academic impact, for papers by Bala Gür Dedeoğlu Breakdown of academic impact, for papers by Yingxia Ning
Rankless by CCL
2026